Skip to main content
Caplight Logo









DeepCardio

DeepCardio

Private
IncheonHealthcare & Life Scienceshttps://deepcardio.com/

Last Round

Series B

Feb 15, 2026

Total Funding Raised

$4.25M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

DeepCardio is a healthcare technology company that provides an AI-based solution to analyze ECG signals for the early prediction and detection of heart diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics, Medical Devices

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

medical AIECG analysisatrial fibrillation detectioncardiovascular risk assessmentAI diagnosticsejection fraction analysisclinical decision supportelectrocardiogramECGdigital healthhealthtecharrhythmia detectioncardiology softwareAI-driven diagnosticspredictive cardiology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DeepCardio Comparables

Compare DeepCardio with similar companies based on industry and business-model similarity.

DeepCardio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Anumana
81%
Holmes AI
79%
Powerful Medical
78%

DeepCardio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 15, 2026
GrantDec 8, 2025
AcceleratorJul 17, 2025
Series AFeb 17, 2022

DeepCardio Investors

Notable investors and investment history

DeepCardio investors
InvestorRounds
DAYLI PartnersSeries A
SoftBank GroupSeries A
SBVASeries A
Enlight VenturesSeries B
Government of South KoreaGrant
QUAD VenturesSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 15, 2026

    $2.1M round raised

  • Feb 15, 2026

    Products used in over 20 major hospitals in Korea.

DeepCardio Filings

Explore SEC and related filing metadata, where available.

DeepCardio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about DeepCardio's valuation, stock price, and market status.

Is DeepCardio a public or private company?

DeepCardio is a private company.

What is the current stock price of DeepCardio?

DeepCardio is a private company with no public stock price. No recent secondary market data is available.

How much is DeepCardio worth (valuation)?

Valuation information for DeepCardio is not publicly available.

Can I buy DeepCardio stock?

DeepCardio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was DeepCardio's last funding round?

DeepCardio's most recent funding round was Series B on February 15, 2026.

Who are the main investors in DeepCardio?

Key investors in DeepCardio include DAYLI Partners, SoftBank Group, Enlight Ventures, QUAD Ventures.

Will DeepCardio IPO soon?

No public IPO plans have been announced for DeepCardio.

How can I track DeepCardio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor DeepCardio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIncheon
Employee Range8
Year Founded2020
Last FundingFeb 15, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?